loadpatents
name:-0.027607917785645
name:-0.019191980361938
name:-0.01314115524292
Mercken; Marc Patent Filings

Mercken; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mercken; Marc.The latest application filed is for "antibodies to pyroglutamate amyloid-b and uses thereof".

Company Profile
11.17.23
  • Mercken; Marc - Turnhout BE
  • Mercken; Marc - Beerse BE
  • Mercken; Marc - Somerville MA
  • Mercken; Marc - Sommerville MA
  • Mercken; Marc - Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-PHF-tau antibodies and uses thereof
Grant 11,365,244 - Mercken , et al. June 21, 2
2022-06-21
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
App 20220177560 - Van Broeck; Bianca ;   et al.
2022-06-09
Antibodies To Pyroglutamate Amyloid-b And Uses Thereof
App 20220106387 - Van Broeck; Bianca ;   et al.
2022-04-07
Antibodies to pyroglutamate amyloid-.beta. and uses thereof
Grant 11,236,155 - Van Broeck , et al. February 1, 2
2022-02-01
Anti-PHF-Tau Antibodies and Uses Thereof
App 20210179696 - Mercken; Marc ;   et al.
2021-06-17
Antibodies to Pyroglutamate Amyloid-β and Uses Thereof
App 20210147528 - Mercken; Marc ;   et al.
2021-05-20
Anti-phf-tau Antibodies And Uses Thereof
App 20210002358 - Van Kolen; Kristof ;   et al.
2021-01-07
Methods of detecting pyroglutamate amyloid beta protein (3pE A.beta.) using anti-3pE A.beta. antibodies
Grant 10,851,156 - Mercken , et al. December 1, 2
2020-12-01
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
App 20200308261 - Van Broeck; Bianca ;   et al.
2020-10-01
Anti-PHF-tau antibodies and uses thereof
Grant 10,766,953 - Mercken , et al. Sep
2020-09-08
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
App 20200165328 - Mercken; Marc ;   et al.
2020-05-28
Anti-PHF-tau antibodies and uses thereof
Grant 10,633,435 - Van Kolen , et al.
2020-04-28
Antibodies to pyroglutamate amyloid-.beta. and uses thereof
Grant 10,519,223 - Mercken , et al. Dec
2019-12-31
Anti-PHF-Tau Antibodies and Uses Thereof
App 20190270793 - Van Kolen; Kristof ;   et al.
2019-09-05
Anti-PHG-tau antibodies and their uses
Grant 10,196,440 - Alderfer , et al. Fe
2019-02-05
Anti-phf-tau Antibodies And Their Uses
App 20180305445 - Alderfer; Christopher ;   et al.
2018-10-25
Anti-phf-tau Antibodies And Uses Thereof
App 20180265575 - Mercken; Marc ;   et al.
2018-09-20
Anti-PHF-tau antibodies and their uses
Grant 10,000,559 - Alderfer , et al. June 19, 2
2018-06-19
Antibodies to Pyroglutamate Amyloid-B and Uses Thereof
App 20180142011 - Mercken; Marc ;   et al.
2018-05-24
Anti-PHF-tau Antibodies and Their Uses
App 20170355758 - Alderfer; Christopher ;   et al.
2017-12-14
Anti-PHF-tau antibodies and their uses
Grant 9,745,371 - Alderfer , et al. August 29, 2
2017-08-29
Anti-PHF-tau Antibodies and Their Uses
App 20160304593 - Alderfer; Christopher ;   et al.
2016-10-20
Anti-PHF-tau antibodies and their uses
Grant 9,371,376 - Alderfer , et al. June 21, 2
2016-06-21
Anti-phf-tau Antibodies And Their Uses
App 20150307600 - Alderfer; Christopher ;   et al.
2015-10-29
Isolated microtubule-associated protein tau peptides and kit
Grant 8,163,873 - Mercken , et al. April 24, 2
2012-04-24
Isolsted Monoclonal - Associated Protein Tau and Kit
App 20110143443 - Mercken; Marc ;   et al.
2011-06-16
Anti-amyloid Antibodies, Compositions, Methods And Uses
App 20100028351 - Mercken; Marc ;   et al.
2010-02-04
Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau
App 20090137051 - Mercken; Marc ;   et al.
2009-05-28
Anti-amyloid antibodies, compositions, methods and uses
App 20060246075 - Mercken; Marc ;   et al.
2006-11-02
Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
App 20060008853 - Mercken; Marc ;   et al.
2006-01-12
Anti-amyloid antibodies, compositions, methods and uses
App 20050129695 - Mercken, Marc ;   et al.
2005-06-16
Monoclonal antibodies directed against the microtubule-associated protein tau
Grant 6,900,293 - Mercken , et al. May 31, 2
2005-05-31
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
App 20030143760 - Vandermeeren, Marc ;   et al.
2003-07-31
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
App 20020001857 - Vandermeeren, Marc ;   et al.
2002-01-03
Monoclonal antibodies directed against the microtubule-associated protein tau
App 20010018191 - Mercken, Marc ;   et al.
2001-08-30
Monoclonal antibodies directed against the microtubule-associated protein tau
Grant 6,238,892 - Mercken , et al. May 29, 2
2001-05-29
Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.
Grant 6,232,437 - Vandermeeren , et al. May 15, 2
2001-05-15
Isolated human tau peptide
Grant 6,010,913 - Vandermeeren , et al. January 4, 2
2000-01-04
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
Grant 5,861,257 - Vandermeeren , et al. January 19, 1
1999-01-19
Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
Grant 5,843,779 - Vandermeeren , et al. December 1, 1
1998-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed